EZZ Life Science Holdings 過去の業績
過去 基準チェック /56
EZZ Life Science Holdings has been growing earnings at an average annual rate of 32.7%, while the Life Sciences industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 31.2% per year. EZZ Life Science Holdings's return on equity is 32.7%, and it has net margins of 10.5%.
主要情報
32.7%
収益成長率
24.7%
EPS成長率
| Life Sciences 業界の成長 | 19.7% |
| 収益成長率 | 31.2% |
| 株主資本利益率 | 32.7% |
| ネット・マージン | 10.5% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
EZZ Life Science Holdings Limited (ASX:EZZ) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
Nov 04
EZZ Life Science Holdings Limited's (ASX:EZZ) Shares Leap 41% Yet They're Still Not Telling The Full Story
Aug 28EZZ Life Science Holdings Limited (ASX:EZZ) Stock Catapults 29% Though Its Price And Business Still Lag The Market
Jun 05There's No Escaping EZZ Life Science Holdings Limited's (ASX:EZZ) Muted Earnings Despite A 28% Share Price Rise
Apr 02Here's Why We Think EZZ Life Science Holdings (ASX:EZZ) Is Well Worth Watching
Feb 09EZZ Life Science Holdings Limited's (ASX:EZZ) Share Price Is Matching Sentiment Around Its Earnings
Oct 18EZZ Life Science Holdings' (ASX:EZZ) Promising Earnings May Rest On Soft Foundations
Mar 06Calculating The Fair Value Of EZZ Life Science Holdings Limited (ASX:EZZ)
Nov 22収支内訳
EZZ Life Science Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 66 | 7 | 38 | 0 |
| 31 Mar 24 | 55 | 5 | 32 | 0 |
| 31 Dec 23 | 44 | 3 | 26 | 0 |
| 30 Sep 23 | 40 | 4 | 24 | 0 |
| 30 Jun 23 | 37 | 4 | 22 | 0 |
| 31 Mar 23 | 31 | 3 | 16 | 0 |
| 31 Dec 22 | 24 | 3 | 11 | 0 |
| 30 Sep 22 | 19 | 2 | 7 | 0 |
| 30 Jun 22 | 15 | 1 | 4 | 0 |
| 31 Mar 22 | 15 | 1 | 5 | 0 |
| 31 Dec 21 | 16 | 1 | 5 | 0 |
| 30 Sep 21 | 19 | 1 | 7 | 0 |
| 30 Jun 21 | 22 | 2 | 9 | 0 |
| 31 Mar 21 | 22 | 2 | 7 | 0 |
| 31 Dec 20 | 21 | 2 | 6 | 0 |
| 30 Sep 20 | 20 | 2 | 4 | 0 |
| 30 Jun 20 | 18 | 2 | 2 | 0 |
| 30 Jun 19 | 11 | 1 | 3 | 0 |
質の高い収益: EZZ has a high level of non-cash earnings.
利益率の向上: EZZ's current net profit margins (10.5%) are higher than last year (9.8%).
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: EZZ's earnings have grown significantly by 32.7% per year over the past 5 years.
成長の加速: EZZ's earnings growth over the past year (91.9%) exceeds its 5-year average (32.7% per year).
収益対業界: EZZ earnings growth over the past year (91.9%) exceeded the Life Sciences industry -5.7%.
株主資本利益率
高いROE: EZZ's Return on Equity (32.7%) is considered high.